Anthem Biosciences consolidated net profit rises 7.10% in the September 2025 quarter
(10 Nov 2025)

Back
Net profit of Anthem Biosciences rose 7.10% to Rs 173.43 crore in the quarter ended September 2025 as against Rs 161.93 crore during the previous quarter ended September 2024. Sales rose 4.78% to Rs 550.03 crore in the quarter ended September 2025 as against Rs 524.96 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales550.03524.96 5
OPM %39.6237.19 -
PBDT263.10219.52 20
PBT229.60199.53 15
NP173.43161.93 7

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew